Dianthus Therapeutics (DNTH) Other Working Capital Changes (2017 - 2025)

Dianthus Therapeutics' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at $1.5 million for Q3 2025.

• On a quarterly basis, Other Working Capital Changes fell 2159.97% year-over-year to -$15.6 million in Q1 2023; TTM through Jun 2023 was -$17.3 million, a 1265.48% decrease from a year earlier, with the FY2022 full-year figure at -$3.1 million, changed N/A from the prior year.
• Other Working Capital Changes retreated to -$15.6 million in Q1 2023 per DNTH's latest filing, from -$836000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at -$692000.0 in Q1 2022 and bottomed at -$15.6 million in Q1 2023.
• The 5-year median for Other Working Capital Changes is -$6000.0 (2023), against an average of $623611.1.
• Biggest YoY gain for Other Working Capital Changes was 3058.0% in 2025; the steepest drop was 4172.0% in 2025.
• Year by year, Other Working Capital Changes stood at -$836000.0 in 2022, then slumped by 1770.69% to -$15.6 million in 2023.
• Per Business Quant, the three latest DNTH Other Working Capital Changes figures stand at -$15.6 million (Q1 2023), -$836000.0 (Q4 2022), and -$812000.0 (Q3 2022).